×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
HOLX – hologic, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
HOLX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/18
01:48 pm
holx
Is Hologic Stock Outperforming the Dow? [Yahoo! Finance]
Low
Report
Is Hologic Stock Outperforming the Dow? [Yahoo! Finance]
3/17
10:11 pm
holx
???????????????????? : ??????? 2035??224????????? ??????9.1%????????????AI????????????? [CNET News]
Low
Report
???????????????????? : ??????? 2035??224????????? ??????9.1%????????????AI????????????? [CNET News]
3/17
08:35 am
holx
1.5 Billion Women Miss Essential Preventive Tests, Despite Uptick in Global Screening Rates [Yahoo! Finance]
Low
Report
1.5 Billion Women Miss Essential Preventive Tests, Despite Uptick in Global Screening Rates [Yahoo! Finance]
3/17
08:00 am
holx
1.5 Billion Women Miss Essential Preventive Tests, Despite Uptick in Global Screening Rates
Low
Report
1.5 Billion Women Miss Essential Preventive Tests, Despite Uptick in Global Screening Rates
2/25
06:23 pm
holx
ImpediMed Appoints Medical Technology Commercialization Expert Erik Anderson to Board of Directors [Yahoo! Finance]
Low
Report
ImpediMed Appoints Medical Technology Commercialization Expert Erik Anderson to Board of Directors [Yahoo! Finance]
2/4
08:15 am
holx
Hologic Receives FDA Approval for Aptima® HPV Assay Primary Screening Option, Expanding Cervical Health Portfolio
Low
Report
Hologic Receives FDA Approval for Aptima® HPV Assay Primary Screening Option, Expanding Cervical Health Portfolio
1/30
07:12 pm
holx
HOLX Stock Slips on Q1 Earnings and Revenue Miss, Margins Crash [Yahoo! Finance]
Low
Report
HOLX Stock Slips on Q1 Earnings and Revenue Miss, Margins Crash [Yahoo! Finance]
1/30
06:06 am
holx
Hologic (NASDAQ:HOLX) had its "hold (c)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Hologic (NASDAQ:HOLX) had its "hold (c)" rating reaffirmed by analysts at Weiss Ratings.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/2
04:31 pm
holx
Form 4 HOLOGIC INC For: Feb 27 Filed by: Liddy Anne M.
Low
Report
Form 4 HOLOGIC INC For: Feb 27 Filed by: Liddy Anne M.
3/2
04:29 pm
holx
Form 4 HOLOGIC INC For: Feb 26 Filed by: Wendell Amy McBride
Low
Report
Form 4 HOLOGIC INC For: Feb 26 Filed by: Wendell Amy McBride
3/2
04:28 pm
holx
Form 4 HOLOGIC INC For: Feb 26 Filed by: Stewart Stacey D.
Low
Report
Form 4 HOLOGIC INC For: Feb 26 Filed by: Stewart Stacey D.
3/2
04:25 pm
holx
Form 4 HOLOGIC INC For: Feb 26 Filed by: Stamoulis Christiana
Low
Report
Form 4 HOLOGIC INC For: Feb 26 Filed by: Stamoulis Christiana
3/2
04:24 pm
holx
Form 4 HOLOGIC INC For: Feb 26 Filed by: Mohtashami Nanaz
Low
Report
Form 4 HOLOGIC INC For: Feb 26 Filed by: Mohtashami Nanaz
3/2
04:22 pm
holx
Form 4 HOLOGIC INC For: Feb 26 Filed by: McMillan Wayde D.
Low
Report
Form 4 HOLOGIC INC For: Feb 26 Filed by: McMillan Wayde D.
3/2
04:21 pm
holx
Form 4 HOLOGIC INC For: Feb 26 Filed by: Madaus Martin D
Low
Report
Form 4 HOLOGIC INC For: Feb 26 Filed by: Madaus Martin D
3/2
04:18 pm
holx
Form 4 HOLOGIC INC For: Feb 26 Filed by: HANTSON LUDWIG
Low
Report
Form 4 HOLOGIC INC For: Feb 26 Filed by: HANTSON LUDWIG
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/19
CDC, public labs have conducted 37,824 COVID-19 tests [MarketWatch]
6.5%
3/18 CDC, public health labs have conducted at least 31,000 tests [MarketWatch] 5.8%
4/23 Hologic, Inc. (NASDAQ: HOLX) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 5.1%
4/2 Hologic, Inc. (NASDAQ: HOLX) had its price target lowered by analysts at Needham & Company LLC from $62.00 to $52.00. They now have a "buy" rating on the stock. 4.8%
4/8 Hologic, Inc. (NASDAQ: HOLX) had its "outperform" rating re-affirmed by analysts at William Blair. 4.7%
11/20 Clayton, Dubilier & Rice to Acquire Market-Leading Medical Aesthetics Technology Company 4.3%
3/9 Form 4 HOLOGIC INC For: Mar 05 Filed by: HANTSON LUDWIG 4.0%
4/7 Form 8-K HOLOGIC INC For: Apr 07 2.9%
3/26 Hologic, Inc. (NASDAQ: HOLX) had its price target lowered by analysts at Barclays PLC from $51.00 to $43.00. They now have an "equal weight" rating on the stock. 2.8%
1/31 Hologic, Inc. (NASDAQ: HOLX) was upgraded by analysts at TheStreet from a "c" rating to a "b+" rating. 2.7%
3/18 CDC, public health labs have conducted at least 31,000 tests [MarketWatch] 5.8%
4/23 Hologic, Inc. (NASDAQ: HOLX) was upgraded by analysts at BidaskClub from a "sell" rating to a "hold" rating. 5.1%
4/2 Hologic, Inc. (NASDAQ: HOLX) had its price target lowered by analysts at Needham & Company LLC from $62.00 to $52.00. They now have a "buy" rating on the stock. 4.8%
4/8 Hologic, Inc. (NASDAQ: HOLX) had its "outperform" rating re-affirmed by analysts at William Blair. 4.7%
11/20 Clayton, Dubilier & Rice to Acquire Market-Leading Medical Aesthetics Technology Company 4.3%
3/9 Form 4 HOLOGIC INC For: Mar 05 Filed by: HANTSON LUDWIG 4.0%
4/7 Form 8-K HOLOGIC INC For: Apr 07 2.9%
3/26 Hologic, Inc. (NASDAQ: HOLX) had its price target lowered by analysts at Barclays PLC from $51.00 to $43.00. They now have an "equal weight" rating on the stock. 2.8%
1/31 Hologic, Inc. (NASDAQ: HOLX) was upgraded by analysts at TheStreet from a "c" rating to a "b+" rating. 2.7%
TOP News Decliners
3/17
Form 8-K HOLOGIC INC For: Mar 16
-11.4%
3/11 Form 4 HOLOGIC INC For: Mar 09 Filed by: CRAWFORD SALLY -9.9%
4/30 Hologic, Inc. (NASDAQ: HOLX) had its price target raised by analysts at Needham & Company LLC from $52.00 to $60.00. They now have a "buy" rating on the stock. -8.1%
3/20 CDC, public health labs performed at least 44,000 COVID-19 tests [MarketWatch] -5.9%
11/7 Hologic, Inc. (HOLX) CEO Steve MacMillan on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] -5.3%
10/1 Hologic CEO Steve MacMillan to Ring Nasdaq Opening Bell on October 2 -4.5%
3/10 Form 8-K HOLOGIC INC For: Mar 05 -4.5%
8/14 Hologic, Inc. (NASDAQ: HOLX) had its price target raised by analysts at Argus to $62.00. They now have a "buy" rating on the stock. -4.4%
3/5 German Lab Demonstrates Feasibility to Detect SARS-Coronavirus-2 (SARS-CoV-2) Using Hologic’s Panther Fusion® System -4.3%
3/21 CDC, public health labs have tested at least 54,205 Americans for coronavirus [MarketWatch] -3.7%
3/11 Form 4 HOLOGIC INC For: Mar 09 Filed by: CRAWFORD SALLY -9.9%
4/30 Hologic, Inc. (NASDAQ: HOLX) had its price target raised by analysts at Needham & Company LLC from $52.00 to $60.00. They now have a "buy" rating on the stock. -8.1%
3/20 CDC, public health labs performed at least 44,000 COVID-19 tests [MarketWatch] -5.9%
11/7 Hologic, Inc. (HOLX) CEO Steve MacMillan on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] -5.3%
10/1 Hologic CEO Steve MacMillan to Ring Nasdaq Opening Bell on October 2 -4.5%
3/10 Form 8-K HOLOGIC INC For: Mar 05 -4.5%
8/14 Hologic, Inc. (NASDAQ: HOLX) had its price target raised by analysts at Argus to $62.00. They now have a "buy" rating on the stock. -4.4%
3/5 German Lab Demonstrates Feasibility to Detect SARS-Coronavirus-2 (SARS-CoV-2) Using Hologic’s Panther Fusion® System -4.3%
3/21 CDC, public health labs have tested at least 54,205 Americans for coronavirus [MarketWatch] -3.7%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: